Dratkiewicz, E.; Simiczyjew, A.; Pietraszek-Gremplewicz, K.; Mazurkiewicz, J.; Nowak, D.
Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment. Int. J. Mol. Sci. 2020, 21, 113.
https://doi.org/10.3390/ijms21010113
AMA Style
Dratkiewicz E, Simiczyjew A, Pietraszek-Gremplewicz K, Mazurkiewicz J, Nowak D.
Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment. International Journal of Molecular Sciences. 2020; 21(1):113.
https://doi.org/10.3390/ijms21010113
Chicago/Turabian Style
Dratkiewicz, Ewelina, Aleksandra Simiczyjew, Katarzyna Pietraszek-Gremplewicz, Justyna Mazurkiewicz, and Dorota Nowak.
2020. "Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment" International Journal of Molecular Sciences 21, no. 1: 113.
https://doi.org/10.3390/ijms21010113
APA Style
Dratkiewicz, E., Simiczyjew, A., Pietraszek-Gremplewicz, K., Mazurkiewicz, J., & Nowak, D.
(2020). Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment. International Journal of Molecular Sciences, 21(1), 113.
https://doi.org/10.3390/ijms21010113